Study finds how bacterial vaccine demonstrates potential as treatment for cancer immunotherapy
NEW YORK: Columbia researchers developed probiotic bacteria that train the immune system to eliminate cancer cells, paving the way for a new class of cancer vaccinations that take advantage of bacteria’s innate tumour-targeting abilities. These microbial cancer vaccines can be tailored to each person’s specific original tumour and metastases, perhaps preventing future recurrences.In mice models … Read more
